Second Death Linked to Potential Antibody Treatment for Alzheimer’s Disease Woman’s brain hemorrhage while receiving Eisai’s widely heralded lecanemab heightens concerns overs its safety
By Charles Piller Global Research, November 30, 2022 Science 27 November 2022 A 65-year-old woman who was receiving a promising experimental treatment to slow the cognitive decline caused by her early Alzheimer’s disease recently died from a massive brain hemorrhage …Source
Related posts:
Not a God: Taiwan Says of Health Minister Amid Uptick in COVID Cases Linked to Quarantine Hotel
Study Finds Potential Link Between Aborted Human DNA Fragments In Vaccines To Autism
Sudan official resigns due to high protest death toll
Brit Papers Claim Hotel Maids Downed Russian Airliner - Veterans Today
‘His only crime was that he’s not Jewish’: Israeli police caught on video attacking Palestinian in T...
Why was Joe Kennedy Jr. true cause of death completely covered up? Roosevelt family?
Views: 0